TXNRD1 and neoplasm: Treatment with curcumin, an irreversible inhibitor of TrxR1 (40), elevated PTEN activity by nearly 3 folds in PyVT(+/−)/ADN(+/−) tumor cells, which was accompanied by the decreased activities of both TrxR1 and Trx1 (Figure 9A).